We hypothesize that the IDO/PD-L1 vaccine attracts T cells into the tumor, which induces type 1 helper T (TH1) cell inflammation and reverts the TME into an immune-permissive site, thereby turning the tumor ‘hot’. This evidence concerns the gene IDO1 and neoplasm.